Skip to content

13F-HR filed by GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 37 holding rows worth $232,821,000.

Accession
0000930413-14-004572
Filed
2014-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 40 entries on the cover page, a total value of $232,821,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $232,821,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HYPERION THERAPEUTICS INC44915N101COM793,864$20,021,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM1,161,739$18,204,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM1,100,000$14,762,000thousands by filing date
ALIMERA SCIENCES INC016259103COM2,619,853$14,200,000thousands by filing date
OPHTHOTECH CORP683745103COM300,000$11,679,000thousands by filing date
ENDOLOGIX INC29266S106COM973,200$10,316,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.011,161,604$9,676,000thousands by filing date
ARADIGM CORP038505400COM NO PAR NEW1,008,062$9,667,000thousands by filing date
AMBIT BIOSCIENCES CORP02318X100COM600,000$9,240,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM1,859,315$9,111,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM264,873$8,200,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock2,474,076$7,917,000thousands by filing date
EXELIXIS INC COM30161Q104Stock5,100,000$7,803,000thousands by filing date
Alcobra LtdM2239P109SHS487,200$7,522,000thousands by filing datecall
ONCOTHYREON INC682324108COM3,907,952$7,503,000thousands by filing date
PAIN THERAPEUTICS INC69562K100COM1,817,889$7,108,000thousands by filing date
AASTROM BIOSCIENCES INC00253U404COM PAR$2,170,000$6,185,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM290,000$6,180,000thousands by filing date
VERACYTE INC COM92337F107Stock607,296$5,921,000thousands by filing date
HEARTWARE INTL INC422368100COM70,000$5,434,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM1,793,942$4,790,000thousands by filing date
SOPHIRIS BIO INC F83578Q209FOREIGN CANADIAN1,585,500$4,646,000thousands by filing date
TENAX THERAPEUTICS INC88032L100COM1,115,497$4,384,000thousands by filing date
VICAL INC925602104COM3,025,000$3,388,000thousands by filing date
CUTERA INC232109108COM315,000$3,182,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW400,000$2,856,000thousands by filing datecall
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares1,431,196$2,748,000thousands by filing date
CHEMOCENTRYX INC16383L106COM483,741$2,177,000thousands by filing date
WAFERGEN BIO-SYSTEMS INC93041P308Cmn421,509$1,834,000thousands by filing date
Onconova Therapeutics68232V108Common345,824$1,487,000thousands by filing date
MEI PHARMA INC55279B202COM NEW157,661$1,088,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW923,534$1,007,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM151,611$702,000thousands by filing date
THORATEC CORP885175307COM22,300$596,000thousands by filing date
Alcobra LtdM2239P109SHS36,200$559,000thousands by filing dateput
CARA THERAPEUTICS INC140755109COM47,321$397,000thousands by filing date
ZAFGEN INC98885E103COM16,855$331,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000930413-14-004572this filing2014-11-14acceptance time not in the bulk data set